The complex relationship between the histopathological features of ductal carcinoma in situ (DCIS) and its hormone receptor status warrants further investigation with a larger sample size to fully understand the underlying mechanisms. This evidence concerns the gene NR4A1 and ductal breast carcinoma in situ.